Detalhe da pesquisa
1.
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.
Immunity
; 49(6): 1148-1161.e7, 2018 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30552023
2.
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.
Immunity
; 55(9): 1749, 2022 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36103861
3.
Prognostic Biomarkers for Melanoma Immunotherapy.
Curr Oncol Rep
; 22(3): 25, 2020 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32048065
4.
Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence.
J Immunol
; 189(2): 767-76, 2012 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22723522
5.
Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity.
Mol Ther Oncolytics
; 25: 174-188, 2022 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35592387
6.
Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor Immunity.
Mol Cancer Res
; 20(6): 983-995, 2022 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35302641
7.
Disruption of TGF-beta signaling prevents the generation of tumor-sensitized regulatory T cells and facilitates therapeutic antitumor immunity.
J Immunol
; 183(6): 3682-9, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19692636
8.
Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti-PD-1 Therapy.
Clin Cancer Res
; 27(9): 2481-2493, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33593880
9.
Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses.
Cancer Immunol Res
; 8(2): 246-254, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31852717
10.
Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma.
Clin Cancer Res
; 26(3): 598-607, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582519
11.
Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma.
Clin Cancer Res
; 26(12): 2827-2837, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32376655
12.
Retroviral Replicating Vector Delivery of miR-PDL1 Inhibits Immune Checkpoint PDL1 and Enhances Immune Responses In Vitro.
Mol Ther Nucleic Acids
; 6: 221-232, 2017 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28325288
13.
Tumor-derived autophagosome vaccine: induction of cross-protective immune responses against short-lived proteins through a p62-dependent mechanism.
Clin Cancer Res
; 17(20): 6467-81, 2011 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21810919
14.
Multiple vaccinations: friend or foe.
Cancer J
; 17(5): 379-96, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21952289
15.
Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectors.
J Gene Med
; 6(12): 1369-81, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15538729